We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.33%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,055

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CO
2826
DELISTED
Global Cord Blood Corporation
CO
$31.7K ﹤0.01%
12,332
CIFR icon
2827
Cipher Digital
CIFR
$7.17B
$30.9K ﹤0.01%
55,186
SUPV
2828
Grupo Supervielle
SUPV
$742M
$30K ﹤0.01%
13,904
-19,270
-58% -$35.3K
EIGR
2829
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$29.5K ﹤0.01%
+833
New +$100K
HLLY icon
2830
Holley
HLLY
$386M
$29.3K ﹤0.01%
+13,823
New +$43.5K
CIFRW
2831
CALL
DELISTED
Cipher Mining Warrant
CIFRW
$27.3K ﹤0.01%
48,720
QTTB icon
2832
Q32 Bio
QTTB
$456M
$26.2K ﹤0.01%
1,154
-522
-31% -$13.9K
NKLA
2833
DELISTED
Nikola Corporation Common Stock
NKLA
$25.4K ﹤0.01%
+392
New +$32.8K
FXE icon
2834
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$341M
$19.8K ﹤0.01%
200
-42,200
-100% -$3.98M
IYR icon
2835
CALL
iShares US Real Estate ETF
IYR
$4.5B
$16.8K ﹤0.01%
200
-15,500
-99% -$1.3M
PDD icon
2836
PUT
Pinduoduo
PDD
$129B
$16.3K ﹤0.01%
200
-1,700
-89% -$118K
MIT.WS
2837
CALL
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$13.3K ﹤0.01%
663,630
MTL
2838
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$11.7K ﹤0.01%
40,326
DUK icon
2839
PUT
Duke Energy
DUK
$95.9B
$10.3K ﹤0.01%
100
CRKN
2840
DELISTED
Crown Electrokinetics Corp. Common Stock
CRKN
0
VLTA
2841
DELISTED
Volta Inc.
VLTA
$6.2K ﹤0.01%
17,209
-149
-0.9% -$113
AA icon
2842
Alcoa
AA
$14.1B
-474,958
Closed -$16M
ABBV icon
2843
CALL
AbbVie
ABBV
$443B
-7,600
Closed -$1.02M
ABCB icon
2844
Ameris Bancorp
ABCB
$5.92B
-5,062
Closed -$226K
ABEV icon
2845
Ambev
ABEV
$44B
-1,846,666
Closed -$5.23M
ABNB icon
2846
Airbnb
ABNB
$112B
-1,130,609
Closed -$114M
ABUS icon
2847
Arbutus Biopharma
ABUS
$928M
-392,932
Closed -$751K
ACGL icon
2848
Arch Capital
ACGL
$33.6B
-8,417
Closed -$382K
ACET icon
2849
Adicet Bio
ACET
$76.9M
-5,284
Closed -$1.2M
ACIW icon
2850
ACI Worldwide
ACIW
$5.28B
-294,162
Closed -$6.15M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,055 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,055 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.